CD5+ B cells from bovine leukemia virus infected cows are activated cycling cells responsive to interleukin 2

J P Matheise1, M Delcommenne, A Mager

  • 1Department of Immunology, University of Namur, Belgium.

Leukemia
|April 1, 1992
PubMed

Insights

Bovine leukemia virus (BLV) infection activates B cells in cows with persistent lymphocytosis (PL). These CD5+ B cells show myeloid markers and cell cycle progression, indicating an activated state.

Area of Science:

  • Veterinary Immunology
  • Bovine Leukemia Virus Research
  • Cellular Immunology

Background:

  • Bovine leukemia virus (BLV) causes persistent lymphocytosis (PL) in infected cows.
  • B cells in PL typically express the CD5 T-cell marker, but their activation status was unclear.

Purpose of the Study:

  • To determine if CD5+ B cells in BLV-infected cows with PL are in an activated state.
  • To investigate the membrane phenotype and cell cycle status of these B cells.

Main Methods:

  • Flow cytometry using CD5, CD11b, and CD11c markers.
  • Cell cycle analysis.
  • In vitro proliferation assays using IL-2 supernatant on T-cell-depleted peripheral blood mononuclear cells.

Main Results:

  • CD5+ B cells in BLV-infected cows also expressed myeloid markers CD11b and CD11c.
  • Over 15% of these B cells showed cell cycle progression beyond the resting G0/G1 phase.
  • T-cell-depleted cells proliferated in response to IL-2, suggesting B-cell activation.

Conclusions:

  • CD5+ B cells in BLV-infected cows with PL exhibit an activated phenotype.
  • These findings suggest a role for activated B cells in the pathogenesis of BLV-associated lymphocytosis.